Appeals Court Upholds Exergen Temporal Artery Thermometer Patent Infringement by Helen of Troy’s Braun and Vicks Forehead Thermometers

The United States Court of Appeals for the Federal Circuit (CAFC) on March 8, 2018 decided the appeal in Exergen v. Kaz, finding Exergen’s 7,787,938 patent valid and infringed by the Vicks V977 Forehead Thermometer and the Braun FHT1000 Forehead Thermometer. Both of these are supplied by Kaz USA, Inc. of Southborough, MA, a subsidiary of Helen of Troy, Ltd of Hamilton, Bermuda. The CAFC decision preserves nearly all of the $16 million in damages awarded Exergen by the January 2016 U.S. District Court of Massachusetts jury verdict.

A recognized world leader in medical and industrial non-invasive temperature technologies, Exergen has been developing and patenting its non-invasive thermometer technology for three decades. The company’s Founder and President, Francesco Pompei, Ph.D., also a Harvard research scientist, is the inventor of nearly 100 patents.

“We are grateful to the U.S. Patent System and the Federal Courts that make it possible for small companies like Exergen to protect its breakthrough patented technology against much larger businesses,” said Dr. Pompei. “This outcome is testament to our commitment to advancing the state-of-the-art to help our customers meet today’s challenges in healthcare. This is in thousands of hospitals and clinics nationwide. To giving millions of moms peace of mind.

Exergen’s patented award-winning TemporalScanner™ temporal artery thermometers are manufactured in Watertown, MA USA from components and materials sourced worldwide.

About Exergen Corporation

Exergen markets two models of the TemporalScanner thermometer: a professional model thermometer for medical use (for doctors’ offices, hospitals, and nurses) and a consumer model thermometer for home use sold in major retailers nationwide.

Nearly two billion temperatures are taken each year with the TemporalScanner, more than with any other thermometer, used in thousands of hospitals, clinics, and pediatricians’ offices across the country, as well as in millions of homes. It is the #1 preference of pediatricians, #1 preference of nurses in the US, and #1 selling retail thermometer.

Supported by more than 70 peer-reviewed published studies, is the Exergen TemporalScanner. They range in covering all ages from preterm infants to geriatrics, and all care areas from hospitals to homes. For additional information, visit www.exergen.com.